NOVEL CRYSTALLINE FORM OF 3,5-DIBROMO-N- [(2S)-2-(-4-FLUOROPHENYL)-4-(3-MORPHOLIN-4-YLAZETIDIN-1-YL)BUTYL] -N-METHYLBENZAMIDE, MODIFICATION A

The present invention relates to a novel crystalline form of 3,5-dibromo-N-[(2S)-2-(4-fluorophenyl)-4-(3-morpholin-4-ylazetidin-1-yl)butyl]-N-methylbenzamide. Further, the present invention also relates to the use of the novel crystalline form for the treatment of gastrointestinal disorders, pharmac...

Full description

Saved in:
Bibliographic Details
Main Author FREDENWALL, MARLENE
Format Patent
LanguageEnglish
French
Published 19.04.2007
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to a novel crystalline form of 3,5-dibromo-N-[(2S)-2-(4-fluorophenyl)-4-(3-morpholin-4-ylazetidin-1-yl)butyl]-N-methylbenzamide. Further, the present invention also relates to the use of the novel crystalline form for the treatment of gastrointestinal disorders, pharmaceutical compositions containing it as well as processes for the preparation of the novel crystalline form. La présente invention concerne une nouvelle forme cristalline de 3,5-dibromo-N-[(2S)-2-(4-fluorophényl)-4-(3-morpholin-4-ylazétidin-1-yl)butyl]-N-méthylbenzamide. La présente invention concerne également l'utilisation de ladite nouvelle forme cristalline pour le traitement de troubles gastro-intestinaux, des compositions pharmaceutiques la contenant, ainsi que des procédés de fabrication de ladite nouvelle forme cristalline.
Bibliography:Application Number: WO2006SE01128